Linden Thomas Advisory Services LLC Sells 63 Shares of HCA Healthcare, Inc. $HCA

Linden Thomas Advisory Services LLC trimmed its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.1% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 630 shares of the company’s stock after selling 63 shares during the period. Linden Thomas Advisory Services LLC’s holdings in HCA Healthcare were worth $241,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Park Place Capital Corp increased its stake in HCA Healthcare by 2,336.0% in the second quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after purchasing an additional 1,168 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in HCA Healthcare by 11.9% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock valued at $8,796,000 after purchasing an additional 2,698 shares in the last quarter. Harrell Investment Partners LLC increased its stake in HCA Healthcare by 176.3% in the second quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock valued at $695,000 after purchasing an additional 1,158 shares in the last quarter. Brown Advisory Inc. increased its position in shares of HCA Healthcare by 53.9% during the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after acquiring an additional 1,622 shares in the last quarter. Finally, Simplicity Wealth LLC increased its position in shares of HCA Healthcare by 92.7% during the second quarter. Simplicity Wealth LLC now owns 1,798 shares of the company’s stock worth $689,000 after acquiring an additional 865 shares in the last quarter. Institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have recently issued reports on HCA. Weiss Ratings reissued a “buy (b-)” rating on shares of HCA Healthcare in a research report on Wednesday, October 8th. Wall Street Zen raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday. Sanford C. Bernstein reissued a “market perform” rating and set a $417.00 price objective on shares of HCA Healthcare in a research report on Monday. Oppenheimer increased their target price on shares of HCA Healthcare from $400.00 to $500.00 and gave the stock an “outperform” rating in a report on Monday. Finally, UBS Group increased their target price on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a report on Monday. Thirteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $471.42.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.30% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of HCA stock opened at $468.68 on Tuesday. The stock has a market cap of $109.67 billion, a P/E ratio of 18.12, a P/E/G ratio of 1.41 and a beta of 1.40. The company has a fifty day moving average price of $416.33 and a two-hundred day moving average price of $383.23. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $469.18.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating analysts’ consensus estimates of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company’s revenue for the quarter was up 9.6% compared to the same quarter last year. During the same quarter last year, the company posted $4.90 earnings per share. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.